BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22674488)

  • 1. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
    McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
    Lina C; Conghua W; Nan L; Ping Z
    J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
    Arthritis Res Ther; 2011 Jul; 13(4):R126. PubMed ID: 21801431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.
    Kosmaczewska A; Ciszak L; Swierkot J; Szteblich A; Kosciow K; Frydecka I
    Inflammation; 2015 Apr; 38(2):765-74. PubMed ID: 25145773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study.
    Szalay B; Vásárhelyi B; Cseh A; Tulassay T; Deák M; Kovács L; Balog A
    Clin Rheumatol; 2014 Feb; 33(2):175-85. PubMed ID: 23934385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.
    Kosmaczewska A; Swierkot J; Ciszak L; Szteblich A; Chrobak A; Karabon L; Partyka A; Szechinski J; Wiland P; Frydecka I
    Rheumatol Int; 2014 Feb; 34(2):243-53. PubMed ID: 24221190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leonurine Regulates Treg/Th17 Balance to Attenuate Rheumatoid Arthritis Through Inhibition of TAZ Expression.
    Du YY; Chen ZX; Liu MY; Liu QP; Lin CS; Chu CQ; Xu Q
    Front Immunol; 2020; 11():556526. PubMed ID: 33117342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
    Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
    Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.
    Hull DN; Williams RO; Pathan E; Alzabin S; Abraham S; Taylor PC
    Clin Exp Immunol; 2015 Sep; 181(3):401-6. PubMed ID: 25766640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
    Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
    Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients.
    Yue C; You X; Zhao L; Wang H; Tang F; Zhang F; Zhang X; He W
    Rheumatol Int; 2010 Nov; 30(12):1553-7. PubMed ID: 19847432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept.
    Blache C; Lequerré T; Roucheux A; Beutheu S; Dedreux I; Jacquot S; Le Loët X; Boyer O; Vittecoq O
    Rheumatology (Oxford); 2011 Oct; 50(10):1814-22. PubMed ID: 21791546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.
    Jin S; Chen H; Li Y; Zhong H; Sun W; Wang J; Zhang T; Ma J; Yan S; Zhang J; Tian Q; Yang X; Wang J
    Ann Rheum Dis; 2018 Nov; 77(11):1644-1652. PubMed ID: 30045854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helios Enhances Treg Cell Function in Cooperation With FoxP3.
    Takatori H; Kawashima H; Matsuki A; Meguro K; Tanaka S; Iwamoto T; Sanayama Y; Nishikawa N; Tamachi T; Ikeda K; Suto A; Suzuki K; Kagami S; Hirose K; Kubo M; Hori S; Nakajima H
    Arthritis Rheumatol; 2015 Jun; 67(6):1491-502. PubMed ID: 25733061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
    Santinon F; Batignes M; Mebrek ML; Biton J; Clavel G; Hervé R; Lemeiter D; Breckler M; Busato F; Tost J; Ziol M; Boissier MC; Decker P; Semerano L; Bessis N
    Arthritis Rheumatol; 2020 Apr; 72(4):576-587. PubMed ID: 31609517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
    Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
    Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.